Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT - Assistant Vice President - Equity Research, Anand Rathi Shares and Stock Brokers.
The fall in the domestic market was subdued compared to carnage seen in global equities
Sebi has barred the three officials from holding any position with any stock exchange, depository, clearing corporation and any intermediary registered with it for two years
Of the amount, $20 million came from co-invest capital from World Bank's IFC and a family office from the Middle East
Jitters already felt in crude, farm goods and base metals; US aims at heart of chinese economy; Beijing's retaliation could have tailspin effect on global trade
Meanwhile, Indian markets got inflows of $12.6 million, most of it going into the equity market
The lender's net profit was Rs 969 crore for the March quarter against Rs 1,020 crore in the year-ago quarter
At the start of the year, YES Bank was ranked 7th
Analysts expect marketing margin concerns, most of which are already priced in, to recede after elections, and say valuations are now attractive
The sharp increase in gross NPAs reflect stress in its loan against property business.
From the 30-share pack, 25 scrips witnessed sell-off led by Yes Bank, Tata Motors, Bajaj Finance, Tata Steel and HDFC
Voltality-measuring index, India VIX, also rose sharply to 10.23 per cent on the day
All that happened in the markets today
The company's Ebitda rose 3.6 per cent at Rs 531 crore in March quarter.
In the past four trading days, the stock has rallied 54 per cent from the level of Rs 76.20 on April 26, 2019, as compared to a 1 per cent decline in the benchmark Nifty 50 index
Brickwork revised ratings of various exiting debt instruments of Reliance Capital and continues the rating on credit watch with negative implications.
The housing finance company reported a net profit of Rs 54.3 crore in March quarter, against Rs 20 crore in the year-ago quarter.
The stock is trading close to its all-time high of Rs 305 touched on September 27, 2018.
ICRA downgraded Yes Bank's tier-I and tier-II bonds and infrastructure debt on deterioration in the credit quality of large ticket borrowers.
The US Food and Drug Administration has issued 14 observations after inspecting the drug firm's manufacturing facility at Moraiya in Ahmedabad.